Center For Financial Planning, Inc. Astrazeneca PLC Transaction History
Center For Financial Planning, Inc.
- $736 Million
- Q3 2024
A detailed history of Center For Financial Planning, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 671 shares of AZN stock, worth $43,239. This represents 0.01% of its overall portfolio holdings.
Number of Shares
671
Previous 671
-0.0%
Holding current value
$43,239
Previous $52,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.05 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.4 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.37 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.23 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...